ELZONRIS.COM: Keyword Density Checker

Total words: 2418 | 2-word phrases: 615 | 3-word phrases: 724 | 4-word phrases: 768

PAGE INFO

Title	Try to keep the title under 60 characters (64 characters) ELZONRIS® (tagraxofusp-erzs) Homepage \| Treatment for BPDCN
Description	Try to keep the meta description between 50 - 160 characters (197 characters) Learn about ELZONRIS, the only approved treatment for blastic plasmacytoid dendritic cell neoplasm. BPDCN symptoms, ELZONRIS side effects. See full Prescribing Information, including Boxed WARNING.
Keywords	Meta keywords are not recommended anymore (197 characters) Learn about ELZONRIS, Hope is rising in BPDCN, FDA-approved, treatment for BPDCN
H1	H1 tag on the page (18 characters) is rising in BPDCN

#	Keyword	Frequency	Density
1	your healthcare provider	14	1.93%
2	treatment with elzonris	8	1.10%
3	any of the	4	0.55%
4	contact your healthcare	4	0.55%
5	feeling tired fatigue	4	0.55%
6	cell neoplasm bpdcn	4	0.55%
7	healthcare provider will	4	0.55%
8	during treatment with	4	0.55%
9	blastic plasmacytoid dendritic	4	0.55%
10	all of the	4	0.55%
11	test your blood	4	0.55%
12	leak syndrome cls	4	0.55%
13	capillary leak syndrome	4	0.55%
14	healthcare provider immediately	4	0.55%
15	if you have	4	0.55%
16	to learn more	4	0.55%
17	if you are	4	0.55%
18	or plan to	4	0.55%
19	immediately if you	4	0.55%
20	symptoms may include	4	0.55%
21	swelling in your	4	0.55%
22	elzonris can cause	4	0.55%
23	therapeutics inc a	3	0.41%
24	important safety information	3	0.41%
25	stemline therapeutics inc	3	0.41%
26	any of these	2	0.28%
27	inc at 18773327961	2	0.28%
28	away may help	2	0.28%
29	right away may	2	0.28%
30	liver damage contact	2	0.28%

#	Keyword	Frequency	Density
1	your healthcare provider immediately	4	0.52%
2	contact your healthcare provider	4	0.52%
3	during treatment with elzonris	4	0.52%
4	your healthcare provider will	4	0.52%
5	capillary leak syndrome cls	4	0.52%
6	fatigue loss of appetite	2	0.26%
7	the whites of your	2	0.26%
8	or the whites of	2	0.26%
9	skin or the whites	2	0.26%
10	your skin or the	2	0.26%
11	of your skin or	2	0.26%
12	yellowing of your skin	2	0.26%
13	breastfeeding or plan to	2	0.26%
14	or plan to breastfeed	2	0.26%
15	it is not known	2	0.26%
16	feeling tired fatigue loss	2	0.26%
17	tired fatigue loss of	2	0.26%
18	of your eyes jaundice	2	0.26%
19	include feeling tired fatigue	2	0.26%
20	may include feeling tired	2	0.26%
21	symptoms may include feeling	2	0.26%
22	tests symptoms may include	2	0.26%
23	is not known if	2	0.26%
24	not known if elzonris	2	0.26%
25	known if elzonris passes	2	0.26%
26	usually detected through blood	2	0.26%
27	is usually detected through	2	0.26%
28	damage is usually detected	2	0.26%
29	liver damage is usually	2	0.26%
30	whites of your eyes	2	0.26%
31	are breastfeeding or plan	2	0.26%
32	your eyes jaundice or	2	0.26%
33	your blood while you	2	0.26%
34	damage contact your healthcare	2	0.26%
35	liver damage contact your	2	0.26%
36	healthcare provider right away	2	0.26%
37	provider right away if	2	0.26%
38	right away if you	2	0.26%
39	elzonris to check for	2	0.26%
40	on elzonris to check	2	0.26%

#	URL	Whois	Check
1	https://stemlinearc.com/patient/ELZONRIS/patient-support/	Whois	stemlinearc.com
2	https://www.fda.gov/medwatch	Whois	fda.gov
3	https://www.fda.gov/medwatch	Whois	fda.gov
4	https://stemline.com/	Whois	stemline.com
5	https://stemline.com/contact/	Whois	stemline.com
6	https://stemline.com/privacy-policy/	Whois	stemline.com
7	https://stemline.com/ccpa-policy/	Whois	stemline.com
8	https://stemline.com/cookie-policy/	Whois	stemline.com
9	https://stemline.com/privacy-policy/	Whois	stemline.com